MRNA Moderna Inc
Company Analysis
Latest News
🟢 Moderna is trading 4.1% up today as shares stabilize following last week's earnings-driven selloff
Moderna is trading 4.07% up now at $57.05 as shares stabilize following last week’s earnings-driven selloff and norovirus trial disappointment. • Investors...
Moderna Posts $782 Million Loss, Hit by $950 Million Patent Settlement
Moderna reported a net loss of $782 million for the second quarter of 2026. Revenue for the period totaled $145 million. This revenue figure remained roughly...
🔴 Moderna is trading 4.6% down today after norovirus vaccine setback outweighs Q2 revenue beat
Moderna is trading 4.6% down now at $55.28 as investors focus on a Phase 3 norovirus vaccine setback that overshadowed a second-quarter revenue beat. • The...
🔴 Moderna is trading 4.5% down today after norovirus vaccine failure and Q2 earnings
Moderna is trading 4.5% down at $55.30 after the company reported Q2 2026 earnings and a clinical setback for its norovirus vaccine candidate. • The company...
Moderna's second quarter revenue of $145 million beats estimates amid a key pipeline setback.
Moderna reported second quarter 2026 revenue of $145 million, up from $142 million in the prior-year period, alongside a net loss per share of $1.97, an...
🟢 Moderna is trading 4.1% up today ahead of Q2 earnings and RSV vaccine traction
Moderna is trading 4.1% up at $60.27 as investors position ahead of its Q2 2026 earnings report on July 31 and monitor early traction for its RSV vaccine,...
🟢 Moderna is trading 4% up today ahead of Q2 earnings and RSV vaccine traction
Moderna is trading 4% up today at $56.68 as investors position ahead of its Q2 2026 earnings report on July 31 and focus on early commercial traction for its...
Moderna Inc Q2 2026 Earnings Preview: What Analysts Expect on July 31, 2026
Moderna is expected to report Q2 2026 revenue of $103.1 million and an EPS loss of $1.97, with its current share price of $55.63 trading above the average...
🟢 Moderna rises 4.3% — Biotech Sector Rallies on Blockbuster M&A Deal and Positive Trial Data
With Biotech (XBI) up 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is experiencing a significant...
🔴 Moderna is trading 4.2% down today amid broader biotech and risk-off pressure
Moderna is trading 4.2% down today at $54.65 amid broader biotech weakness and risk-off sentiment. • The decline extends a multi-session slide for the stock,...
Moderna Flu Vaccine Outperforms Standard Shots, Sustaining Immune Response for Six Months
Moderna’s investigational flu vaccine, mRNA-1010, produces a broader and more durable antibody response than conventional shots. A study in Nature Immunology...
Moderna Alleges Breach of Agreement in COVID-19 Vaccine Patent Lawsuit with CureVac
Moderna countered a patent-infringement lawsuit from CureVac. Moderna claims the legal action violates a prior agreement between the two biotech firms. In a...
Moderna Plunges 7%, Following $3.6 Million Insider Sale
Moderna, Inc. (MRNA) shares fell 7.51% in a single trading session. The stock price closed at $63.15. President Stephen Hoge sold approximately $3.6 million...
🔴 Moderna is trading 4.3% down today as Sanofi files new patent infringement lawsuits
Moderna is trading 4.3% down at $65.32 following news that Sanofi has filed new patent infringement lawsuits against the company in U.S. federal court. •...
Moderna Stock Tumbles Over 10% Following JPMorgan Sell Rating
Moderna (MRNA) shares fell sharply on Friday, July 10, declining by as much as 12%. The drop was primarily triggered after JPMorgan reaffirmed its "Sell"...
🔴 Moderna is trading 10.2% down
Moderna is trading at $68.77, down 10.2% from a comparison close of $76.56 during regular trading. This is a price-action follow-up, so a separate catalyst may...
🔴 Moderna is trading 7.2% down today after a sharp multi-week rally and valuation concerns
Moderna is trading 7.2% down at $71.05 following a sharp multi-week rally as concerns linger that its valuation has outpaced underlying fundamentals. • Shares...
🔴 MRNA extends move to 6.1% down
MRNA is trading at $74.94, down 6.1% versus the comparison close of $79.77 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 MRNA is trading 4.1% down today on a technical pullback and broader risk-off sentiment
MRNA is trading 4.1% down at $76.53 as the stock undergoes a technical pullback following a sharp rally over the past week. • The move appears to be a...
🔴 MRNA is trading 4.1% down today in a pullback from recent strength
MRNA is trading 4.1% down at $78.45 as the stock pulls back from a sharp run-up over the prior week. • There is no clear company-specific news catalyst for...